Aster DM Valuation
| ASTERDM Stock | 436.00 3.00 0.69% |
At this time, the firm appears to be overvalued. Aster DM Healthcare shows a prevailing Real Value of USD374.72 per share. The current price of the firm is USD436.0. Our model approximates the value of Aster DM Healthcare from analyzing the firm fundamentals such as Current Valuation of 218.97 B, return on equity of 0.0699, and Profit Margin of 1.28 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 6.2783 | Enterprise Value 219 B | Enterprise Value Ebitda 26.9297 | Price Sales 5.2888 | Forward PE 12.6103 |
Overvalued
Today
Please note that Aster DM's price fluctuation is very steady at this time. Calculation of the real value of Aster DM Healthcare is based on 3 months time horizon. Increasing Aster DM's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aster stock is determined by what a typical buyer is willing to pay for full or partial control of Aster DM Healthcare. Since Aster DM is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aster Stock. However, Aster DM's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 436.0 | Real 374.72 | Hype 434.59 | Naive 439.0 |
The intrinsic value of Aster DM's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aster DM's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aster DM Healthcare helps investors to forecast how Aster stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aster DM more accurately as focusing exclusively on Aster DM's fundamentals will not take into account other important factors: Aster DM Cash |
|
Aster DM Total Value Analysis
Aster DM Healthcare is presently projected to have takeover price of 218.97 B with market capitalization of 217.46 B, debt of 13.84 B, and cash on hands of 500.3 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aster DM fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
218.97 B | 217.46 B | 13.84 B | 500.3 M |
Aster DM Investor Information
About 54.0% of the company shares are held by company insiders. The company last dividend was issued on the 10th of February 2025. Aster DM Healthcare is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 1.7 B | 1.8 B |
|
| |||||
| Operating Income | 11.4 B | 10.8 B |
|
|
Aster DM Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aster DM has an asset utilization ratio of 20.56 percent. This suggests that the Company is making USD0.21 for each dollar of assets. An increasing asset utilization means that Aster DM Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.Aster DM Ownership Allocation
Aster DM holds a total of 498.13 Million outstanding shares. Aster DM Healthcare retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aster DM Profitability Analysis
The company reported the revenue of 36.99 B. Net Income was 1.29 B with profit before overhead, payroll, taxes, and interest of 22.83 B.About Aster DM Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Aster DM Healthcare. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Aster DM Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Aster DM's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Aster DM's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aster DM. We calculate exposure to Aster DM's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aster DM's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 22.7 B | 21.6 B |
Other Information on Investing in Aster Stock
Aster DM financial ratios help investors to determine whether Aster Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aster with respect to the benefits of owning Aster DM security.